IQgenomyx improves clinical trials using advanced genetic screening. Our genetic insights platform helps find the best patients before they join a trial. This is done by looking at genetic markers, which helps avoid expensive problems and trial failures.
Find the Right Patients
Identify patients whose genes affect how they respond to drugs. This helps you choose the best groups for your treatment.
Keep Patients in Trials & Work Efficiently
Reduce the number of patients who drop out by checking for genetic reasons that might cause side effects or no response, making trials smoother.
Custom Genetic Intelligence for Your Clinical Trial
Develop parallel genetic tests that become companion diagnostics for your approved therapeutics, creating additional value streams.
Our customized genetic reports deliver actionable insights tailored to your trial objectives, directly impacting development timelines and success.
Put Genomics to Work for Your Next Trial
Novel Therapeutic Development
Accelerate drug development by identifying genetic responder populations early, allowing you to design more targeted trials with clearer efficacy signals and fewer subjects needed.
Multi-Site Trial Management
Standardize patient selection across all trial locations with our portable genetic screening kits and centralized analysis platform, ensuring consistent cohort quality globally.
Risk Mitigation
Proactively identify and exclude patients with genetic variants associated with adverse reactions to your compound class, reducing safety incidents and potential regulatory concerns.
Whether you're developing a breakthrough therapeutic or managing complex multi-site trials, IQgenomyx provides the genetic intelligence tools to help you recruit smarter, move faster, and minimize risk throughout your clinical development process.